Claims for Patent: 5,053,491

Summary for Patent: 5,053,491

Title:	Monoclonal antibodies and cell lines for parathyroid tissue-specific antigen
Abstract:	Monoclonal antibodies specific for an antigen present on the surface of parathyroid tissue are useful in imaging such tissue when conjugated to suitable label. The antibodies of the invention bind exclusively to parathyroid surfaces and do not bind to other tissues. The antibodies are useful in establishing the location of the parathyroid whether in its normal location or in ectopic placements. An exemplary monoclonal has been deposited at the American Type Culture Collection and has accession number ATCC No. HB9917.
Inventor(s):	Cance; William G. (St. Louis, MO), Davie; Joseph M. (St. Louis, MO), Wells, Jr.; Samuel A. (St. Louis, MO), Dilley; William G. (St. Louis, MO), Welch; Michael J. (St. Louis, MO), Morrissey, IV; Jeremiah J. (St. Louis, MO)
Assignee:	Washington University School of Medicine (St. Louis, MO)
Application Number:	07/342,312
Patent Claims:	1. Monoclonal antibodies specifically immunoreactive with a human parathyroid tissue-specific antigen not secreted by said gland, wherein said antibodies are not immunoreactive with other human tissue, and wherein said antigen has an apparent molecular weight of 191 kd (non-reduced) and an apparent molecular weight of 171 kd (reduced) on SDS-polyacylamide gel electrophoresis and wherein said antigen is found on the surface of parathyroid tissue. 2. The antibodies of claim 1 which are of class IgM. 3. The antibodies of claim 1 which are of class IgGl. 4. Subfragments of the antibodies of claim 1 which retain antigen specificity. 5. The subfragments of claim 4 which are Fab or F(ab').sub.2 subfragments. 6. An immortalized cell line which secretes monoclonal antibodies of claim 1. 7. The immortalized cell line of claim 6 which is a hybridoma. 8. The hybridoma of claim 7 which is prepared by fusing blood lymphocytes or spleen cells from mice immunized with isolated human parathyroid tissue with a murine myeloma line. 9. The monoclonal antibodies of claim 1 covalently bound to label. 10. The subfragments of claim 4 covalently bound to label. 11. The monoclonal antibodies of claim 9 wherein the label is radioactive. 12. The subfragments of claim 10 wherein the label is radioactive. 13. The monoclonal antibodies of claim 11 wherein the label is I-125, In-111, or Tc-99. 14. The subfragments of claim 12 wherein the label is I-125, In-111, or Tc-99. 15. The monoclonal antibodies of claim 1 wherein said antibodies, when bound to the parathyroid gland, enhance the secretion of parathyroid hormone.

Details for Patent 5,053,491

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Nps Pharmaceuticals, Inc.	NATPARA	parathyroid hormone	For Injection	125511	01/23/2015		2039-02-26